Examination of Products for Defects. 6.9.1 Customer must promptly examine and test the Products for (a) defect and non-conformity with any applicable cGMP standards that the Products are required to meet under this agreement, and (b) in the case of Product manufactured to Specification and released with a Certificate of Analysis, the failure of the Product to meet Specification (a “Defect”). Product that is not specified in the Work Statement to meet cGMP cannot be considered Defective Product.
Appears in 2 contracts
Samples: Development and Manufacturing Services Agreement (Harpoon Therapeutics, Inc.), Development and Manufacturing Services Agreement (CytoDyn Inc.)
Examination of Products for Defects. 6.9.1 Customer must promptly [* * *] examine and test the Products for (a) defect and non-conformity non‑conformity with any applicable cGMP standards that the Products are required to meet under this agreementAgreement, and (b) in the case of Product manufactured to Specification and released with a Certificate of Analysis, the failure of the Product to meet Specification (each a “Defect”). Product that is not specified in the Work Statement to meet cGMP cannot be considered Defective Product[* * *].
Appears in 1 contract
Samples: Development and Manufacturing Services Agreement (Catalyst Biosciences, Inc.)
Examination of Products for Defects. 6.9.1 6.7.1 Customer must promptly examine and test the Products for (a) defect and non-conformity with any applicable cGMP standards that the Products are required to meet under this agreement, and (b) in the case of Product manufactured to Specification and released with a Certificate of Analysis, the failure of the Product to meet Specification (a “DefectDefective Product”). Product that is not specified in the Work Statement to meet cGMP cannot be considered Defective Product.
Appears in 1 contract
Samples: Development and Manufacturing Services Agreement (Horizon Therapeutics Public LTD Co)